Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1293|16|9|544-552

ISSN： 1464-2662

Source： HIV MEDICINE, Vol.16, Iss.9, 2015-10, pp. : 544-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting liver fibrosis outcome in HCV/HIV coinfection

By  

HIV MEDICINE, Vol. 16, Iss. 4, 2015-04 ,pp. : 211-218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistently elevated abnormal B‐cell subpopulations and anti‐core antibodies in patients co‐infected with HIV/HCV who relapse

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 4, 2015-04 ,pp. : 544-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

By  

HIV MEDICINE, Vol. 19, Iss. 3, 2018-03 ,pp. : 216-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune activation in leishmania/HIV‐1 coinfection

By  

HIV MEDICINE, Vol. 16, Iss. 4, 2015-04 ,pp. : 240-248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors

By Latronico Tiziana   Mascia Claudia   Pati Ilaria   Zuccala Paola   Mengoni Fabio   Marocco Raffaella   Tieghi Tiziana   Belvisi Valeria   Lichtner Miriam   Vullo Vincenzo   Mastroianni Claudio Maria   Liuzzi Grazia Maria  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-03 ,pp. : 455-455

MDPI

Access to resources Recommend Favorite